NUDT1 and head and neck squamous cell carcinoma: We also showed that MTH1 expression was upregulated under hypoxic conditions in HNSCC, suggesting that MTH1 may be a useful therapeutic target for hypoxic HNSCC with aggressive or treatment-resistant characteristics.